We are live on ! Find out more
HMC

Harvard Management Company Portfolio holdings

AUM $1.82B
1-Year Est. Return 26.23%
This Fund
S&P 500
This Quarter Est. Return
+28.13%
1 Year Est. Return
+26.23%
3 Year Est. Return
+156.3%
5 Year Est. Return
+133.98%
10 Year Est. Return
+221.37%
AUM
$952M
AUM Growth
+$145M
Cap. Flow
-$15.2M
Cap. Flow %
-1.6%
Top 10 Hldgs %
83.36%
Holding
48
New
2
Increased
Reduced
2
Closed

Top Buys

Rank Stock Value
1
PATH icon
UiPath
PATH
+$1.04M
2
LOCO icon
El Pollo Loco
LOCO
+$514K

Top Sells

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$8.74M
2
PLRX icon
Pliant Therapeutics
PLRX
+$8.01M

Sector Composition

Rank Sector Weight
1 Communication Services 51.57%
2 Consumer Discretionary 16.94%
3 Technology 16.01%
4 Healthcare 11.54%
5 Industrials 2.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
1
Alphabet (Google) Class A
GOOGL
$3.91T
$250M 26.28%
2,411,540
META icon
2
Meta Platforms (Facebook)
META
$1.51T
$241M 25.29%
1,135,916
LNW
3
DELISTED
Light & Wonder
LNW
$161M 16.9%
2,678,571
GRAB icon
4
Grab
GRAB
$13.5B
$39.2M 4.12%
13,036,482
ABCL icon
5
AbCellera Biologics
ABCL
$1.62B
$31M 3.25%
4,105,095
NVDA icon
6
NVIDIA
NVDA
$5.01T
$18.4M 1.94%
663,680
PCT icon
7
PureCycle Technologies
PCT
$1.17B
$17.5M 1.84%
2,498,170
ASML icon
8
ASML
ASML
$675B
$13.7M 1.44%
20,186
AMD icon
9
Advanced Micro Devices
AMD
$851B
$11M 1.15%
112,137
AMAT icon
10
Applied Materials
AMAT
$426B
$10.9M 1.14%
88,443
ADI icon
11
Analog Devices
ADI
$181B
$10.8M 1.13%
54,568
QRVO icon
12
Qorvo
QRVO
$7.63B
$10.6M 1.12%
104,669
TXG icon
13
10x Genomics
TXG
$5.87B
$10.4M 1.09%
186,143
MEKA
14
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
$10.2M 1.07%
1,000,000
LRCX icon
15
Lam Research
LRCX
$382B
$10.1M 1.07%
191,310
RXRX icon
16
Recursion Pharmaceuticals
RXRX
$1.57B
$10.1M 1.06%
1,509,254
TSM icon
17
TSMC
TSM
$2.09T
$9.98M 1.05%
107,294
RLAY icon
18
Relay Therapeutics
RLAY
$4.02B
$8.91M 0.94%
541,124
PLRX icon
19
Pliant Therapeutics
PLRX
$67.5M
$7.48M 0.79%
281,189
-281,190
-50% -$8.01M
EQRX
20
DELISTED
EQRx, Inc. Common Stock
EQRX
$7.48M 0.79%
3,853,367
RVMD icon
21
Revolution Medicines
RVMD
$40.2B
$6.83M 0.72%
315,550
-354,832
-53% -$8.74M
INTC icon
22
Intel
INTC
$466B
$6.79M 0.71%
207,752
MU icon
23
Micron Technology
MU
$1.04T
$6.49M 0.68%
107,522
RKLB icon
24
Rocket Lab Corp
RKLB
$39.9B
$4.04M 0.42%
1,000,000
CFLT
25
DELISTED
Confluent
CFLT
$3.14M 0.33%
130,383

Similar funds

Harvard Management Company's Q1 2023 Portfolio in Review

As of Q1 2023, Harvard Management Company held 48 positions worth $952M, up 18% from $807M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 4.2%. Harvard Management Company opened 2 new positions and made no exits, leaving the 48-position portfolio largely intact.

By sector, the portfolio is most concentrated in Communication Services at 52% of assets, up from 43% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Harvard Management Company's largest Q1 2023 buy was UiPath: 69,073 shares worth $1.21M.
  • Harvard Management Company's biggest Q1 2023 reduction was Revolution Medicines, cutting an estimated $8.74M.
  • Harvard Management Company's ten largest holdings make up 83% of its $952M portfolio in Q1 2023.
  • Harvard Management Company opened 2 new positions and closed 0 in Q1 2023.
  • Harvard Management Company's portfolio value rose 18% quarter-over-quarter to $952M.

Based on Harvard Management Company's 13F filing for Q1 2023, filed 15 May 2023.